Bright Minds Biosciences, Inc. (DRUG.CX)
123.46
+0.68
(+0.55%)
CAD |
CNSX |
May 29, 16:00
Bright Minds Biosciences Total Liabilities (Quarterly) : 3.833M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Fennec Pharmaceuticals, Inc. | 47.65M |
| Microbix Biosystems, Inc. | 10.22M |
| Helix BioPharma Corp. | 3.164M |
| Sernova Biotherapeutics, Inc. | 26.62M |
| Covalon Technologies Ltd. | 5.162M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 312.37M |
| Shareholders Equity (Quarterly) | 308.53M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 81.48 |
| Net Debt Paydown Yield | -0.00% |